GeneOnline

@GeneOnlineNews

We are a premier biotech media providing in-depth biopharma insights, top KOL interviews, and the latest news on research breakthroughs and global events.

Vrijeme pridruživanja: srpanj 2017.

Tweetovi

Blokirali ste korisnika/cu @GeneOnlineNews

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @GeneOnlineNews

  1. 5. velj

    Seqirus’ AUDENZTM, a vaccine for a potential pandemic associated with the H5N1 flu virus commonly known as “bird flu” was approved by the on Monday.

    Poništi
  2. 4. velj

    February 4th, observed as the World Cancer Day aims to raise global awareness about prevention, detection, and treatment of cancer. This year's theme is "I Am and I Will" and puts the focus on our commitment to act.

    Poništi
  3. 4. velj

    Here's an interesting read from "Step aside CRISPR, RNA editing is taking off"

    Poništi
  4. 4. velj

    0127-0202 1. Companies Developing Vaccine 2. Tests Ebola Drug as New Coronavirus Treatment 3. Commences Joint Research and Development of Cancer Gene Panel Test with Personal Genome Diagnostics

    Poništi
  5. 3. velj

    New Jersey based biopharma, Incorporated today reported positive Phase II results for INS1007, a potential for treating non-cystic fibrosis (NCFBE). The company’s stocks skyrocketed 36% upon release of the news.

    Poništi
  6. 2. velj

    The has issued 6 new guidances to enhance the development of new gene therapy products. The policies are drafted to regulate the rapidly progressing field and preserve the agency's motto of supporting innovations.

    Poništi
  7. 1. velj

    Mammoth Biosciences (), co-founded by gene-editing technology pioneer, Jennifer Doudna, has raised $45 million in funding. The company plans to funnel the funds into expanding in the direction of CRISPR based .

    Poništi
  8. 1. velj

    Aimmune Therapeutics () announce approval of its oral immunotherapy drug, PALFORZIA™ for the treatment of children between ages 4 and 17 who suffer from peanut allergy. With this, the drug became the first treatment for .

    Poništi
  9. 31. sij

    The First designed investigational enzyme replacement therapy, Olipudase Alfa succeeds in Phase II/III trial that evaluated it for the treatment of Niemann-Pick Disease.

    Poništi
  10. 31. sij

    The World Health Organization officially declares the novel coronavirus outbreak as a Public Health Emergency of International Concern (PHEIC) following a second meeting on January 30.

    Poništi
  11. 30. sij
    Poništi
  12. 30. sij

    held in Taiwan at the beginning of 2020 is mainly hosted by . Well-known experts& scholars from different parts of Asia gathered in Taiwan to share the latest trends& research in human microbiome.

    Poništi
  13. 29. sij

    A collaborative study led by researchers from the Technical University of Munich (TUM) has demonstrated the successful use of CRISPR-Cas9 to correct the defective dystrophin gene in a pig model of Duchenne Muscular Dystrophy.

    Poništi
  14. 28. sij

    With the success in 2019, the BIO Asia-Taiwan International Conference and Exhibition, jointed by Taiwan Bio Industry Organization (Taiwan BIO) and the US-based Bio Innovation Organization (BIO) will be held AGAIN in 2020! Apply to exhibit NOW:

    Poništi
  15. 28. sij

    Dr. Nagendra Chemuturi of discussed duration of action, Biodistribution &other challenges of in his talk "Role of Modeling & Simulation in Development" organized by . He stressed the importance of doing what's meaningful for the product.

    Poništi
  16. proslijedio/la je Tweet
    26. sij

    News & Views: A study published in Nature identifies the mechanism governing premature greying in mice that have experienced stress.

    Poništi
  17. 24. sij

    In another step towards fighting relapsed Diffuse Large B-Cell Lymphoma (DLBCL), a type of blood cancer, scores EU approval for its novel combination therapy involving the antibody-drug conjugate, Polivy.

    Poništi
  18. 23. sij

    0113-0119 1. LATEST Trends on Cell Therapy in Taiwan 2. 2019–20 outbreak of novel ( ) 3. and Partners to Identify and Develop Preclinical Candidates

    Poništi
  19. 22. sij

    On January 21st, Dublin based Horizon Therapeutics received the early authorization of its human monoclonal antibody, Tepezza. With this, the drug became the first and only approved treatment for Thyroid Eye Disease (TED), a rare autoimmune disorder.

    Poništi
  20. 22. sij

    The intestinal flora, which was often forgotten in the past, was warmly discussed at the 4th Asia Microbiome Conference, which was held in Taiwan at the beginning of 2020. More conference insights on

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·